
Neurointerventional Medical Device Developer
On December 3, 2025, at the "10th Zhitong Finance Listed Company Awards Ceremony" jointly hosted by Zhitong Finance and New Wisdom Fund Network, and exclusively organized by Winter Sunshine Donova, HeartCare (06609) won the "Most Valuable Healthcare Company" award for its professional capabilities and outstanding performance in the medical and health services field.

The "Most Valuable Healthcare Company" award is presented to Hong Kong and U.S.-listed medical institutions and health service providers that demonstrate professional diagnostic and treatment capabilities, efficient service systems, forward-looking technology strategies, the ability to offer convenient and high-quality healthcare services to the public, and the capacity to generate consistent and stable returns for investors. The fact that HeartCare-B (06609) received this award fully reflects the capital market's high recognition of its professional service capabilities, innovative service model, and long-term investment value.
"The 10th Zhitong Finance Listed Company Awards," launched in 2016, has been a highly authoritative and credible annual event in China's capital market for ten consecutive years. This year’s selection lasted over a month, involving multiple stages such as company self-nomination, multi-dimensional data screening, and authoritative expert reviews. Companies were comprehensively evaluated based on performance growth, industry ranking, corporate governance, market returns, and ESG performance, ultimately selecting benchmark enterprises across various fields.
During the selection period, it attracted the active participation of over a thousand Hong Kong and US-listed companies, covering emerging high-growth sectors such as artificial intelligence, biotechnology, advanced manufacturing, and green technology, while also encompassing traditional mainstream industries like finance, energy, consumer goods, real estate, and transportation. This fully demonstrates the broad representation and industry depth of the selection.
At the award ceremony, more than 170 professionals from banks, securities, insurance, trusts, and leading asset management institutions gathered together with renowned economists, investment opinion leaders, and thousands of investors. They engaged in in-depth discussions on asset allocation strategies under the global liquidity turning point and the investment opportunities in Hong Kong stocks in 2026. Through the exchange of ideas, market consensus gradually formed, and the long-term value revaluation path of Chinese assets became increasingly clear.
Honor witnesses strength, and value shapes the future. We look forward to all award-winning enterprises taking this as an opportunity to continuously enhance core competitiveness, deepen social responsibility practices, create steady returns for investors, and contribute more to promoting high-quality economic development and sustainable social progress.